We, and others, have demonstrated that genetic deficiency of the early components of the classical complement pathway, including C1q and C4 [5], is strongly associated with the development of SLE [6], an autoimmune rheumatic disease with a marked increased risk of vascular morbidity and mortality, which is not fully explained by traditional risk factors. The gene discussed is C4A; the disease is systemic lupus erythematosus.